Loading...
XJPX5187
Market cap49mUSD
Jan 14, Last price  
916.00JPY
1D
-0.22%
1Q
-2.14%
Jan 2017
-4.28%
Name

Create Medic Co Ltd

Chart & Performance

D1W1MN
XJPX:5187 chart
P/E
51.27
P/S
0.63
EPS
17.87
Div Yield, %
4.25%
Shrs. gr., 5y
-0.46%
Rev. gr., 5y
3.11%
Revenues
12.59b
+2.68%
9,058,880,0009,017,696,0009,097,359,0009,325,368,0009,331,915,0009,880,617,0009,939,799,0009,650,702,00010,003,003,00010,393,563,00010,796,964,00010,843,961,00010,830,471,00011,698,682,00012,257,294,00012,585,449,000
Net income
154m
-68.06%
810,326,000625,496,000667,541,000583,382,000512,271,000533,628,000490,059,000333,143,000516,695,000467,961,000672,536,000725,054,000659,523,000660,409,000482,213,000154,022,000
CFO
699m
+51.48%
1,279,163,0001,003,964,000672,213,000864,538,000322,661,000951,028,0001,223,346,000715,900,0001,443,976,000524,432,000797,921,000880,331,0001,249,020,0001,248,681,000461,344,000698,839,000
Dividend
Dec 27, 202420 JPY/sh

Profile

Create Medic Co., Ltd. researches, develops, manufactures, and sells medical appliances in Japan and internationally. The company offers disposable medical devices made of silicone resin. It provides various urology, gastroenterology, percutaneous endoscopic gastrostomy, and surgery products. The company also provides other products, such as CLINY tracheostomy tubes, endotracheal tubes, tracheostomy tubes, and microcatheters. In addition, it offers OEM products comprising multi-lumen tubes, ultrathin walls, profile extrusions, and special structures; special shape and high-volume low-pressure cuff moldings; and hydrophilic coating and needles, as well as the technology on an OEM basis. The company was formerly known as NASK Co., Ltd. and changed its name to Create Medic Co., Ltd. in July 1977. Create Medic Co., Ltd. was incorporated in 1974 and is headquartered in Yokohama, Japan.
URL
http://www.createmedic.co.jp/
IPO date
Jul 19, 2000
Employees
1,117
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
12,585,449
2.68%
12,257,294
4.77%
Cost of revenue
7,957,109
7,764,872
Unusual Expense (Income)
NOPBT
4,628,340
4,492,422
NOPBT Margin
36.78%
36.65%
Operating Taxes
750,001
376,096
Tax Rate
16.20%
8.37%
NOPAT
3,878,339
4,116,326
Net income
154,022
-68.06%
482,213
-26.98%
Dividends
(335,705)
(336,046)
Dividend yield
4.13%
4.20%
Proceeds from repurchase of equity
(62)
4,441
BB yield
0.00%
-0.06%
Debt
Debt current
800,000
800,000
Long-term debt
84,777
107,767
Deferred revenue
Other long-term liabilities
1,130,827
1,069,838
Net debt
(3,962,318)
(3,945,938)
Cash flow
Cash from operating activities
698,839
461,344
CAPEX
(435,000)
(359,592)
Cash from investing activities
(363,614)
38,014
Cash from financing activities
(362,190)
(355,587)
FCF
3,210,111
3,670,662
Balance
Cash
4,392,845
4,305,977
Long term investments
454,250
547,728
Excess cash
4,217,823
4,240,840
Stockholders' equity
13,964,060
13,747,206
Invested Capital
12,657,372
12,223,346
ROIC
31.18%
33.96%
ROCE
27.08%
26.87%
EV
Common stock shares outstanding
9,102
9,098
Price
892.00
1.36%
880.00
-10.11%
Market cap
8,119,244
1.41%
8,006,219
-10.08%
EV
4,156,926
4,060,281
EBITDA
5,216,488
5,092,674
EV/EBITDA
0.80
0.80
Interest
10,979
7,078
Interest/NOPBT
0.24%
0.16%